Arginine deprivation therapy for malignant melanoma

Despite recent development of promising immunotherapeutic and targeted drugs, prognosis in patients with advanced melanoma remains poor, and a cure for this disease remains elusive in most patients. The success of melanoma therapy depends on a better understanding of the biology of melanoma and deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Jung-Ki, Frankel, Arthur E, Feun, Lynn G, Ekmekcioglu, Suhendan, Kim, Kevin B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534294/
https://www.ncbi.nlm.nih.gov/pubmed/23293541
http://dx.doi.org/10.2147/CPAA.S37350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534294/
https://www.ncbi.nlm.nih.gov/pubmed/23293541
http://dx.doi.org/10.2147/CPAA.S37350

Ejemplares similares